Short Biography Anna Maria Papini, Phd Professor and Chair Of

Short Biography Anna Maria Papini, Phd Professor and Chair Of

Short Biography Anna Maria Papini, PhD Professor and Chair of Bioorganic Chemistry _______________________________________________________________________________________ Interdepartmental French-Italian Laboratory of Peptide & Protein Chemistry & Biology www.peptlab.eu Education and Scientific Graduation Since 2013: Scientific National Habilitation to the function of Full Professor of Organic Chemistry of the Italian Universities. Since 2001: Habilitation to the function of Full Professor of Organic Chemistry of the French Universities. 1985-1989: International Ph.D. in Chemical Biology of the Italian Ministry of Education. 1985-1986 Department of Biochemistry, University of Sherbrooke, Québec, Mentor Prof. Dr. Gilles Dupuis; 1986-1988 Dept. of Organic Chemistry, University of Florence, Mentor: Prof. Gianfranco. Rapi and 1988-1989 Department of Peptide Chemistry, Max Planck Institute für Biochemie, Martinsried Bei Muenchen, Mentor Prof. Dr. Luis Moroder. 1977-1983: Italian “Laurea” in Chemistry, Curriculum Organic Chemistry & Chemical Biology of the University of Florence (Italy). Research Experience and Employment History Since 2002 to date: Associate Professor and Chair of Bioorganic Chemistry of the University of Florence. Since 2008 to date: Full Professor and Chair of Bioorganic Chemistry of the University of Cergy-Pontoise. Since 2010 to date: Founder and coordinator of the French-Italian Laboratory of Peptide & Protein Chemistry & Biology ( www.peptlab.eu ) University of Florence & University of Cergy-Pontoise. Since 2013 to date: Director of the Platform PeptLab@UCP at the University of Cergy-Pontoise. Since 2004 to date: Co-founder and head of the Interdepartmental Laboratory of Peptide & Protein Chemistry & Biology, Polo Scientifico of the University of Florence associating the Departments of Chemistry, Pharmaceutical Sciences & Neurosciences of the University of Florence. 1991-2001: Researcher at the Department. of Organic Chemistry, University of Florence. Awards and Activities in the Scientific Community 2009-2014: Chaire d’excellence of the French Agence Nationale de la Recherche . 2008: Leonidas Zervas Award for outstanding contribution to peptide chemistry, 30th EPS, Helsinki. 2008: 1st D. Theodoropoulos Memorial Lecture Award for outstanding achievements in Peptide Sciences, 6th Hellenic Forum on Bioactive Peptides, Patras. 2005: Bert Schram Price. Honorable Mention, 19th APS, San Diego, CA, USA. 2005: Best Poster Award “Glyco XVIII”, Firenze. 1999: Bruce W. Erickson Award for outstanding achievement in peptide sciences, 16th APS, Minneapolis, Minnesota, USA. 2012-2016: Panel Member for ERC Advanced Grant evaluation PE5 – Synthetic chemistry and materials. 2016: Chairperson of the 2016 GRC: Chemistry & Biology of Peptides with Prof. Dr. P. Dawson. 2014: Chairperson of the Symposium & Training Course Peptides in Paris PIPS 2014 (Co-chairs Prof. S. Lavielle & Prof. W.D. Lubell), October 5-10, 2014, Institute if Advanced Studies, University of Cergy-Pontoise (France). 2014: Responsible of the thematic semester Peptides & Proteins Molecules of Life at the University of Cergy-Pontoise. 2014: Vice-chair of the GRC: Peptide Science in the Era of Synthetic Biology. Ventura, CA, 23-28/02/2014. 2011-2020: Treasurer and member of the Executive Committee of the European Peptide Society. February 2011: Member of the AERES Committee for evaluation of the ICM of the University of Reims. March 2010: Member of the AERES Committee for evaluation of iBiTecc-S Equipe SIMOPRO (CEA, Saclay). Since 2013: Coordinator of the International Affairs of the School of Sciences of the University of Florence. Since 2005: Delegate of Chemistry of the Erasmus Programme of the Faculty of Sciences of the University of Florence. Responsible of the Erasmus students 2009: Vespucci Award for founding the startup Toscana Biomarkers. 2008: Frost & Sullivan Excellence in Research Award in the European autoimmune disease diagnostics market presented to AMP for the startup Toscana Biomarkers. 2006: Start-Cup for business plan of the start-up Toscana Biomarkers. 2004: Vespucci Award, Research & Ethical Innovation to AMP as inventor of PCT (2003) WO 03000733 A2 . 2007 to date: Founder & Chief Scientific Officer of the startup Toscana Biomarkers (www.toscanabiomarkers.com ) 2003: Founder and member of the Board of EspiKem, 1st spinoff of the University of Florence (www.espikem.com) Recent Research Funding 2009-2014: “Chaire d’Excellence” (ANR-09-CEXC-013-01). PepKit: Development of peptide-based- diagnostic kits for autoimmune diseases. 999.998,00 Euro for the PeptLab@UCP platform. 2011-2013: “Fondation Pierre-Gilles de Gennes”. Immune-mediated diseases: Glycopeptidomic-based diagnostics to follow-up disease activity. 2 post-doctoral fellows + 90.000 Euro for materials. 2010-2012: “Regione Toscana POR CReO FESR”. MARK: Identification of diagnostic biomarkers of autoimmune diseases. 450.000,00 Euro. 2005-2011: “Fondazione Cassa di Risparmio di Firenze”. Molecular characterisation of peptide-protein interaction in autoimmune diseases. 1.500.000 Euro for PeptLab at University of Florence. 2005-2007: International FIRB- Italian Ministry of University & Research and Harvard Medical School. 350.000,00 Euro. 2002-2003, 2005-2006, 2008-2009: PRIN-Italian Ministry of University & Research. Design, synthesis & immunological characterisation of modified peptides to follow up autoimmune diseases. 700.000,00 Euro. Selected topic-relevant research publications Author of 281 peer-reviewed articles: 111 articles in peer reviewed scientific journals and 170 articles in peer reviewed books. Author of 10 filed patents. Full paper list is available at www.peptlab.eu 1. A.M. Papini , F. Nuti, F. Real-Fernandez, G. Rossi, C. Tiberi, G. Sabatino, S. Pandey, S. Leoncini, C. Signorini, A. Pecorelli, R. Guerranti, S. Lavielle, L. Ciccoli, P. Rovero, C. De Felice, J. Hayek. Immune dysfunction in Rett syndrome patients revealed by high levels of serum anti-N(Glc) IgM antibody fraction. J. Immunology Res. (http://www.hindawi.com/journals/jir/raa/260973/ ). Accepted 15 September 2014 . 2. A. Naegeli, C. Neupert, Y-Y Fan, C-W Chia-Wei Lin, K. Poljak, A.M. Papini , F. Schwarz, M. Aebi. Molecular analysis of an alternative N-glycosylation machinery by functional transfer from Actinobacillus pleuropneumoniae to Escherichia coli. J. Biol. Chem. (2014 ), 24, 289, 2170-2179. 3. S. Pandey, I. Dioni, D. Lambardi, F. Real-Fernandez, E. Peroni, G. Pacini, F. Lolli, R. Seraglia, A.M. Papini , and P. Rovero. Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope. Mol. Cell. Proteomics (2013) Feb;12(2):277-82. 4. S. Pandey, M.C. Alcaro, M. Scrima, E. Peroni, I. Paolini, S. Di Marino, F. Barbetti, A. Carotenuto, E. Novellino, A.M. Papini , A.M. D'Ursi, and P. Rovero. Designed glycopeptides mimetics of myelin protein epitopes as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis. J.Med.Chem. (2012 ) Dec 13;55(23):10437-47. 5. C. Testa, F. Nuti, J. Hayek, C. De Felice, M. Chelli, P. Rovero, G. Latini, and A.M. Papini. Di(2- ethylhexyl)phthalate and Autism Spectrum Disorders. ASN NEURO (American Society for Neurochemistry) (2012 ) 4(4), 223-229 6. F. Nuti, E. Peroni, F. Real-Fernández, M.A. Bonache, A. Le Chevalier-Isaad, M. Chelli, N. Lubin-Germain, J. Uziel, P. Rovero, F. Lolli, and A.M. Papini . Post-translationally modified peptides efficiently mimicking neo- antigens: a challenge for theragnostics of autoimmune diseases. Biopolymers: Peptide Science (2010 ) 94, 6, 791-799. 7. A.M. Papini . The use of post-translationally modified peptides for detection of biomarkers of immune- mediated diseases. J. Pept. Sci . ( 2009), 15, 621-628. 8. A. Carotenuto, M.C. Alcaro, M.R. Saviello, E. Peroni, F. Nuti, A.M. Papin i, E. Novellino, and P. Rovero. Designed glycopeptides with different β-turn types as synthetic probes for the detection of autoantibodies, biomarkers of Multiple Sclerosis. J. Med. Chem . ( 2008 ) 51 , 5304-5309. 9. A. Carotenuto, A.M. D’Ursi, B. Mulinacci, I. Paolini, F. Lolli, A.M. Papini , E. Novellino, and P. Rovero. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis. J. Med. Chem . (2006 ) 49 , 5072-5079. 10. F. Lolli, B. Mulinacci, A. Carotenuto, B. Bonetti, G. Sabatino, B. Mazzanti, A.M. D’Ursi, E. Novellino, M. Pazzagli, L. Lovato, M.C. Alcaro, E. Peroni, M.C. Pozo-Carrero, F. Nuti, L. Battistini, G. Borsellino, M. Chelli, P. Rovero, and A.M. Papini . An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of Multiple Sclerosis. Proc. Natl. Acad. Sci., U.S.A. (2005 ) 102 (29 ), 10273-10278. 11. A.M. Papini . Simple test for Multiple Sclerosis. Nature Medicine (2005 ) 11(1), 13. 12. F. Lolli, B. Mazzanti, M. Pazzagli, E. Peroni, M.C. Alcaro, R. Lanzillo, V. Brescia Morra, L. Santoro, C. Gasperini, S. Galgani, M.M. D’ Elios, V. Zipoli, S. Sotgiu, M. Pugliatti, P. Rovero, M. Chelli, and A.M. Papini . The glycopeptide CSF114(Glc) detects serum antibodies in Multiple Sclerosis. J. Neuroimmunol. (2005 ) 167 (1-2), 131-137. Communication of the scientific activity 2001-2014: invited to present 94 lectures in International Symposia, Universities and Research Centres. 1997-2014: 38 oral & 206 poster communications selected in international symposia. 2009-2013: invited to present 10 lectures aimed to technology transfer in the global space of R&D (2 in extra-European

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    85 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us